191 related articles for article (PubMed ID: 35116534)
1. Survival outcomes for patients with four treatments in stages I-III esophageal squamous cell carcinoma: a SEER analysis.
Wu J; Yang J; Lin X; Lin L; Jiang W; Xie C
Transl Cancer Res; 2021 May; 10(5):2144-2152. PubMed ID: 35116534
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma.
Lin Z; Chen YY; Liu CH; Panzuto F; Ramirez RA; Lang M; Kim H; Ding ZY
J Gastrointest Oncol; 2023 Dec; 14(6):2309-2323. PubMed ID: 38196527
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
Pan L; Zhang Y; Gao Y; Qiu J
Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
[TBL] [Abstract][Full Text] [Related]
4. Prognostic evaluation of esophageal cancer patients with stages I-III.
Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
[TBL] [Abstract][Full Text] [Related]
5. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
Gong L; Mao W; Chen Q; Jiang Y; Fan Y
Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
[TBL] [Abstract][Full Text] [Related]
6. Patterns of metastasis and prognosis of elderly esophageal squamous cell carcinoma patients in stage IVB: a population-based study.
Qiu G; Zhang H; Wang F; Zheng Y; Wang Y
Transl Cancer Res; 2021 Nov; 10(11):4591-4600. PubMed ID: 35116316
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and prognostic features of the patients with esophageal squamous cell carcinomas as a first primary malignancy].
Wen Z; Zhang YQ; Wu R; Peng XM; Chen B; Leng AM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Jul; 37(4):407-414. PubMed ID: 34374262
[No Abstract] [Full Text] [Related]
8. Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008.
Worni M; Martin J; Gloor B; Pietrobon R; D'Amico TA; Akushevich I; Berry MF
J Am Coll Surg; 2012 Nov; 215(5):643-51. PubMed ID: 23084493
[TBL] [Abstract][Full Text] [Related]
9. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
10. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for 495 nonoperative esophageal squamous cancer patients receiving IMRT plus chemotherapy: A retrospective analysis.
Gao Q; Liu ZY; Cheng Y; Di XK; Zhang YM; Sun XC; Xia XJ; Ge XL
Cancer Radiother; 2022 Nov; 26(8):1002-1007. PubMed ID: 35933288
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of hospital volume on the postoperative prognosis of 158,618 patients with esophageal squamous cell carcinoma in China.
Lei LL; Song X; Zhao XK; Xu RH; Wei MX; Sun L; Wang PP; Yang MM; Hu JF; Zhong K; Han WL; Han XN; Fan ZM; Wang R; Li B; Zhou FY; Wang XZ; Zhang LG; Bao QD; Qin YR; Chang ZW; Ku JW; Yang HJ; Yuan L; Ren JL; Li XM; Wang LD
Front Oncol; 2022; 12():1056086. PubMed ID: 36873301
[TBL] [Abstract][Full Text] [Related]
13. Associations of ATM Polymorphisms With Survival in Advanced Esophageal Squamous Cell Carcinoma Patients Receiving Radiation Therapy.
Du Z; Zhang W; Zhou Y; Yu D; Chen X; Chang J; Qiao Y; Zhang M; Huang Y; Wu C; Xiao Z; Tan W; Lin D
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):181-9. PubMed ID: 26094126
[TBL] [Abstract][Full Text] [Related]
14. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract][Full Text] [Related]
15. Clinical Application Value of the Prognostic Nutritional Index for Predicting Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy or Radiotherapy.
Xiao L; Lyu J; Liu X; Li K; Wang Y; Zhang R; Chen T; Li T
Nutr Cancer; 2021; 73(10):1933-1940. PubMed ID: 33044092
[TBL] [Abstract][Full Text] [Related]
16. Treatment and survival analysis for 40-year SEER data on upper esophageal cancer.
Wu X; Zhu MC; Li GL; Xiong P; Sun W; Zhang N; Zhao B; Li LQ; Fu XN; Zhu M
Front Med (Lausanne); 2023; 10():1128766. PubMed ID: 37529246
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy Combined With Concurrent Nedaplatin-Based Chemotherapy for Stage II-III Esophageal Squamous Cell Carcinoma.
Zhu H; Lu X; Jiang J; Lu J; Sun X; Zuo Y
Dose Response; 2022; 20(1):15593258221076720. PubMed ID: 35273471
[TBL] [Abstract][Full Text] [Related]
18. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy of triplet regimens of docetaxel/cisplatin/5-FU (DCF NAC) may improve patient prognosis of cStage II/III esophageal squamous cell carcinoma-propensity score analysis.
Yamashita K; Katada N; Moriya H; Hosoda K; Mieno H; Katada C; Koizumi W; Hoshi K; Watanabe M
Gen Thorac Cardiovasc Surg; 2016 Apr; 64(4):209-15. PubMed ID: 26868531
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
